432 related articles for article (PubMed ID: 9169687)
41. Is the upgrade rate of atypical ductal hyperplasia diagnosed by core needle biopsy of calcifications different for digital and film-screen mammography?
McLaughlin CT; Neal CH; Helvie MA
AJR Am J Roentgenol; 2014 Oct; 203(4):917-22. PubMed ID: 25247961
[TBL] [Abstract][Full Text] [Related]
42. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?
Jackman RJ; Birdwell RL; Ikeda DM
Radiology; 2002 Aug; 224(2):548-54. PubMed ID: 12147855
[TBL] [Abstract][Full Text] [Related]
43. Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential.
Schwartz GF; Carter DL; Conant EF; Gannon FH; Finkel GC; Feig SA
Cancer; 1994 Mar; 73(6):1660-5. PubMed ID: 8156493
[TBL] [Abstract][Full Text] [Related]
44. Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities.
Zhao L; Freimanis R; Bergman S; Shen P; Perrier ND; Lesko N; Pulaski T; Pulaski S; Carr JJ; Levine EA
Am Surg; 2003 Sep; 69(9):757-62; discussion 762. PubMed ID: 14509322
[TBL] [Abstract][Full Text] [Related]
45. Mammographic-histopathologic correlation of large-core needle biopsies of the breast.
Ioffe OB; Berg WA; Silverberg SG; Kumar D
Mod Pathol; 1998 Aug; 11(8):721-7. PubMed ID: 9720499
[TBL] [Abstract][Full Text] [Related]
46. Stereotactic core needle biopsy of multiple sites in the breast: efficacy and effect on patient care.
Rosenblatt R; Fineberg SA; Sparano JA; Kaleya RN
Radiology; 1996 Oct; 201(1):67-70. PubMed ID: 8816522
[TBL] [Abstract][Full Text] [Related]
47. Ductal carcinoma in situ of the breast: Evaluation of main presentations on magnetic resonance imaging compared with findings on mammogram and histology.
Badan GM; Roveda D; Paito S; Fleury Ede F; Maragno B; Campos MS; Ferreira CA; Ferreira FA
Rev Assoc Med Bras (1992); 2016; 62(5):421-7. PubMed ID: 27656851
[TBL] [Abstract][Full Text] [Related]
48. Stereotaxic core biopsy of impalpable spiculated breast masses.
Liberman L; Dershaw DD; Rosen PP; Cohen MA; Hann LE; Abramson AF
AJR Am J Roentgenol; 1995 Sep; 165(3):551-4. PubMed ID: 7645467
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings.
Lee CH; Egglin TK; Philpotts L; Mainiero MB; Tocino I
Radiology; 1997 Mar; 202(3):849-54. PubMed ID: 9051045
[TBL] [Abstract][Full Text] [Related]
50. Efficiency of Core Biopsy for BI-RADS-5 Breast Lesions.
Wolf R; Quan G; Calhoun K; Soot L; Skokan L
Breast J; 2008; 14(5):471-5. PubMed ID: 18821933
[TBL] [Abstract][Full Text] [Related]
51. Incidence of breast cancer in patients with pure flat epithelial atypia diagnosed at core-needle biopsy of the breast.
Khoumais NA; Scaranelo AM; Moshonov H; Kulkarni SR; Miller N; McCready DR; Youngson BJ; Crystal P; Done SJ
Ann Surg Oncol; 2013 Jan; 20(1):133-8. PubMed ID: 23064777
[TBL] [Abstract][Full Text] [Related]
52. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?
Eby PR; Ochsner JE; DeMartini WB; Allison KH; Peacock S; Lehman CD
Ann Surg Oncol; 2008 Nov; 15(11):3232-8. PubMed ID: 18696163
[TBL] [Abstract][Full Text] [Related]
53. Follow-up of benign results of stereotactic core breast biopsy.
Adler DD; Light RJ; Granstrom P; Hunter TB; Hunt KR
Acad Radiol; 2000 Apr; 7(4):248-53. PubMed ID: 10766097
[TBL] [Abstract][Full Text] [Related]
54. Cancelled stereotactic biopsy of calcifications not seen using the stereotactic technique: do we still need to biopsy?
Brennan SB; D'Alessio D; Liberman L; Giri D; Brogi E; Morris EA
Eur Radiol; 2014 Apr; 24(4):907-12. PubMed ID: 24217642
[TBL] [Abstract][Full Text] [Related]
55. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia.
Jackman RJ; Nowels KW; Shepard MJ; Finkelstein SI; Marzoni FA
Radiology; 1994 Oct; 193(1):91-5. PubMed ID: 8090927
[TBL] [Abstract][Full Text] [Related]
56. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy.
Brem RF; Behrndt VS; Sanow L; Gatewood OM
AJR Am J Roentgenol; 1999 May; 172(5):1405-7. PubMed ID: 10227526
[TBL] [Abstract][Full Text] [Related]
57. Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.
Grimm LJ; Johnson DY; Johnson KS; Baker JA; Soo MS; Hwang ES; Ghate SV
Eur Radiol; 2017 Jun; 27(6):2275-2281. PubMed ID: 27752832
[TBL] [Abstract][Full Text] [Related]
58. [Stereotactic 11-gauge directional vacuum-assisted breast biopsy: experience with 249 patients].
Travade A; Isnard A; Bagard C; Bouchet F; Chouzet S; Gaillot A; Vilmant R
J Radiol; 2002 Sep; 83(9 Pt 1):1063-71. PubMed ID: 12223915
[TBL] [Abstract][Full Text] [Related]
59. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
60. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
